IntraBio Revenue and Competitors
Estimated Revenue & Valuation
- IntraBio's estimated annual revenue is currently $450.8k per year.
- IntraBio's estimated revenue per employee is $32,200
- IntraBio's total funding is $50M.
- IntraBio's current valuation is $1B. (March 2024)
Employee Data
- IntraBio has 14 Employees.
- IntraBio grew their employee count by 17% last year.
IntraBio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President & CEO | Reveal Email/Phone |
2 | Senior Advisor to the Chairman & Founder | Reveal Email/Phone |
3 | Chief Development Officer & President, Product Development | Reveal Email/Phone |
4 | Chief Operating Officer | Reveal Email/Phone |
5 | US Chief Medical Officer | Reveal Email/Phone |
6 | Chief Business Officer | Reveal Email/Phone |
7 | VP Supply Chain | Reveal Email/Phone |
8 | VP Finance | Reveal Email/Phone |
9 | VP, Finance | Reveal Email/Phone |
10 | Field Medical Director | Reveal Email/Phone |
IntraBio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2M | 20 | 5% | N/A | N/A |
#2 | $3.8M | 34 | N/A | N/A | N/A |
#3 | $0.5M | 7 | -12% | N/A | N/A |
#4 | $6.7M | 53 | 26% | N/A | N/A |
#5 | $4.4M | 39 | N/A | N/A | N/A |
#6 | $0.6M | 8 | -11% | N/A | N/A |
#7 | $1.3M | 15 | N/A | N/A | N/A |
#8 | $13.6M | 97 | -18% | $22.1M | N/A |
#9 | $4M | 36 | 3% | N/A | N/A |
#10 | $21.9M | 142 | -41% | N/A | N/A |
What Is IntraBio?
IntraBio Inc is a private pharmaceutical company located in London, United Kingdom, focusing on drug development and commercialization related to common and rare neurodegenerative diseases, as well as ageing and healthspan.
keywords:N/A$50M
Total Funding
14
Number of Employees
$450.8k
Revenue (est)
17%
Employee Growth %
$1B
Valuation
N/A
Accelerator
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.9M | 14 | -12% | N/A |
#2 | $2.1M | 14 | -7% | N/A |
#3 | $1.2M | 14 | 0% | N/A |
#4 | $0.5M | 14 | -18% | $57M |
#5 | $1.7M | 14 | -7% | N/A |
